FDA Inspection
NYU Langone Health HospitalNYU Langone Health Hospital – FDA Inspection, May 18, 2017
Record Details
This FDA Inspection record concerns NYU Langone Health Hospital, with an inspection on May 18, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · ebaa2e1a-96b3-4c3a-b466-450b60389b56
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1015463
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 606.160(b)Required records
- 21 CFR 606.160(a)(1)Concurrent documentation
- 21 CFR 606.100(b)(8)Methods for pre-transfusion testing
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of NYU Langone Health Hospital
8| Date | Classification | Office | Project area |
|---|---|---|---|
| June 27, 2025 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 26, 2024 | VAI | New York District Office | Blood and Blood Products |
| August 19, 2022 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 9, 2015 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 25, 2013 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for NYU Langone Health Hospital
- FDA Inspection 1274509 - 2025-06-27
- FDA Inspection 1250142 - 2024-09-26
- FDA Inspection 1177868 - 2022-08-19
- FDA Inspection 922842 - 2015-04-09
- FDA Inspection 822206 - 2013-03-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.